Tempest Therapeutics, Inc. Investment Income, Interest
Tempest Therapeutics, Inc. (TPST) reported Investment Income, Interest of $44.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2015-05-11
- Tempest Therapeutics, Inc. investment income, interest for the quarter ending 2015-03-31 was $44.00K.
- Tempest Therapeutics, Inc. investment income, interest for the quarter ending 2014-03-31 was -$57.00K, a 416.67% decline year-over-year.
- Tempest Therapeutics, Inc. investment income, interest for the quarter ending 2013-12-31 was $13.00K, a 23.53% decline year-over-year.
- Tempest Therapeutics, Inc. investment income, interest for the quarter ending 2013-09-30 was $34.00K, a 1600.00% increase year-over-year.
- Tempest Therapeutics, Inc. investment income, interest for fiscal 2014 was -$126.00K, a 240.00% decline from fiscal 2013.
- Tempest Therapeutics, Inc. investment income, interest for fiscal 2013 was $90.00K, a 373.68% increase from fiscal 2012.
- Tempest Therapeutics, Inc. investment income, interest for fiscal 2012 was $19.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 18 month | Investment Income, Interest 21 month | Investment Income, Interest 24 month | Investment Income, Interest 27 month | Investment Income, Interest 30 month | Investment Income, Interest 33 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $44.00K 10-Q · filed 2015-05-11 | |||||||||
| 2014-12-31 | -$126.00K 10-K · filed 2015-03-16 | |||||||||
| 2014-03-31 | -$57.00K 10-Q · filed 2015-05-11 | -$44.00K derived: sum of 2 quarters · filed 2015-05-11 | -$10.00K derived: sum of 3 quarters · filed 2015-05-11 | $15.00K derived: sum of 4 quarters · filed 2015-05-11 | ||||||
| 2013-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $47.00K derived: sum of 2 quarters · filed 2015-03-16 | $72.00K derived: sum of 3 quarters · filed 2015-03-16 | $90.00K 10-K · filed 2015-03-16 | $109.00K 10-K · filed 2014-02-27 | |||||
| 2013-09-30 | $34.00K 10-Q · filed 2013-11-13 | $59.00K derived: sum of 2 quarters · filed 2013-11-13 | $77.00K 10-Q · filed 2013-11-13 | $94.00K derived: sum of 4 quarters · filed 2015-03-16 | $96.00K 10-Q · filed 2013-11-13 | |||||
| 2013-06-30 | $25.00K 10-Q · filed 2013-08-13 | $43.00K 10-Q · filed 2013-08-13 | $60.00K derived: sum of 3 quarters · filed 2015-03-16 | $62.00K derived: sum of 4 quarters · filed 2015-03-16 | $62.00K 10-Q · filed 2013-08-13 | |||||
| 2013-03-31 | $18.00K 10-Q · filed 2013-05-15 | $35.00K derived: sum of 2 quarters · filed 2015-03-16 | $37.00K derived: sum of 3 quarters · filed 2015-03-16 | $37.00K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $19.00K derived: sum of 2 quarters · filed 2015-03-16 | $19.00K 10-K · filed 2015-03-16 | $19.00K 10-K · filed 2013-02-25 | ||||||
| 2012-09-30 | $2.00K 10-Q · filed 2013-11-13 | $2.00K 10-Q · filed 2013-11-13 | $2.00K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |